维普中文期刊产品整合服务
59篇 您的检索式:作者名="Chlebowski R"
    题名 作者 年代 出处 被引量
1Estrogen plus progestin and risk of benign proliferative breast disease显示文摘Rohan T E Negassa A Chlebowski R T 0,,09:1
2Randomized Trial of Denosunlab in Patients Receiving Adjuvant Aromatase lnhibitors for Nonmetastatic Breast Cancer显示文摘Ellis GK Bone HG Chlebowski R 2008J Clin Oneol2008,26,30:1
3Body size,physical ac- tivity, and risk of triple-negative and estrogen receptor-positive breast cancer显示文摘Phipps AI Chlebowski RT Prentice R 2011Cancer Epidemiol Biomarkers Prey2011,20,:1
4Alkaline phosphatase from Atlantic cod (Gadusmorhua) kinetic andstructural properties which indicate adaptation to low tem- peratures显示文摘Asgerisson B Hartemink R Chlebowski J F 1995Comp Biochem Physiol1995,,110:1
5Body size, physical activity, and risk of triple-negative and estrogen recep- tor-positive breast cancer显示文摘PHIPPS AI CHLEBOWSKI RT PRENTICE R 2011Cancer Epidemiol Biomarkers Prey2011,20,3:1
6Alkaline phos- phatase from Atlanticcod ( Gadus morhua) Kinetic and struc- tural properties which indicate adaptation to low temperatures 显示文摘Asgerisson B Hartemink R Chlebowski JF 1995Comparative Biochemistry and Physiology1995,,:1
7Breast cancer and nonsteroidalanti- inflammatory drugs: prospective results from the women's health initiative显示文摘Harris R E Chlebowski R T Jackson R D 2003Cancer Res2003,63,15:1
8Alkaline phospha tase from Atlantic cod(Gadus morhua):Kinetic and structural properties which indicate adaptation to low temperatures显示文摘Asgerisson B Hartemink R Chlebowski J F 1995Comp Biochem Physiol1995,,:1
9Body size,physical activity,and risk of triple-negative and estrogen receptor-positive breast cancer显示文摘Phipps AI Chlebowski RT Prentice R 0,,03:1
10Randomized trial of denosum- ab in patients receiving adjuvant aromatase inhibitors for nonmetastatic breast cancer显示文摘Ellis GK Bone HG Chlebowski R 2008J Clin Oncol2008,26,30:1
11Bone health in women with early - stage breast cancer显示文摘CHLEBOWSKI R T 2005Clin Breast Cancer2005,5,2:1
12Body size, physical activity, and risk of triple-negative and estrogen receptor-positive breast cancer显示文摘Phipps AI Chlebowski RT Prentice R 2011Cancer Ep- idemiol Biomarkers Prey2011,20,3:1
13Sex Hormone Levels and Risk of Breast Cancer With Estrogen Plus Progestin显示文摘Farhat G N Parimi N Chlebowski R T 2013J Nat Cancer Inst2013,105,19:1
14Breast cancer and nonsteroidalanti-inflammatory drugs:prospective results from the women's health initiative显示文摘Harris R E Chlebowski R T Jackson R D 2003Cancer Res2003,63,15:1
15Breast cancer after use of estrogen plus progestin in postmenopausal women显示文摘Chlebowski R T Kuller L H Prentice R L 2009N Engl J Med2009,360,6:1
16Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women:the Wamen's Health Initiative Randomized Trial显示文摘Chlebowski R T Hendrix S L Langer R D 2003JAMA2003,289,24:1
17Body mass index, physical activity,and survival after endometrial cancer diagnosis: results from the Women's Health Initiative 显示文摘Arem H Chlebowski R Stefanick ML 2013Gynecol Oncol2013,128,:1
18Risks and benefits of therapy with menopausal hormones versus selective estrogen - receptor modulators in peri - and postmenopansal women at increased breast cancer risk显示文摘Col N F Chlebowski R T 2008Menopause2008,15,4:1
19Management of bloody nipple discharge显示文摘VARGAS H I ROMERO L CHLEBOWSKI R T 2002Curr Treat Options Oncol2002,3,2:1
20American society of clinical oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer 显示文摘Hillner B Ingle J Chlebowski R etal 2003J Clin Oncol2003,21,40:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费